Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M FARBER

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
The British Journal of Dermatology|June 26, 2001
Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkineS P Raychaudhuri, W Y Jiang, E M Farber
Acta Dermato-Venereologica|April 16, 1998
Psoriatic keratinocytes express high levels of nerve growth factorS P Raychaudhuri, W Y Jiang, E M Farber
Archives of Dermatology|August 1, 1980
Response of chronic psoriatic plaques to localized heating induced by ultrasoundE K Orenberg, D G Deneau, E M Farber
Cutis|December 1, 1985
Coexistent psoriasis and lupus erythematosus: what's happening?C H Hu, B M O'Connell, E M Farber
International Journal of Immunopharmacology|December 16, 1998
Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasisS K Raychaudhuri, S P Raychaudhuri, E M Farber
Archives of Dermatology|May 1, 1983
Long-term risks of psoralen and UV-A therapy for psoriasisE M Farber, E A Abel, A J Cox
Cutis|December 3, 1999
Search for the psoriasis susceptibility gene: the Newfoundland StudyL Nall, W Gulliver, P Charmley, et al.
Archives of Dermatology|April 1, 1975
Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivityV S Constantine, Z Y Fuks, E M Farber
Cancer|December 1, 1973
Prognostic signs and the management of the mycosis fungoidesZ Y Fuks, M A Bagshaw, E M Farber
International Journal of Dermatology|October 1, 1987
Psoriasis Day Care Center at Stanford. Part-time and full-time programsE A Abel, B M O'Connell, E M Farber
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
The British Journal of Dermatology|June 26, 2001
Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkineS P Raychaudhuri, W Y Jiang, E M Farber
Acta Dermato-Venereologica|April 16, 1998
Psoriatic keratinocytes express high levels of nerve growth factorS P Raychaudhuri, W Y Jiang, E M Farber
Archives of Dermatology|August 1, 1980
Response of chronic psoriatic plaques to localized heating induced by ultrasoundE K Orenberg, D G Deneau, E M Farber
Cutis|December 1, 1985
Coexistent psoriasis and lupus erythematosus: what's happening?C H Hu, B M O'Connell, E M Farber
International Journal of Immunopharmacology|December 16, 1998
Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasisS K Raychaudhuri, S P Raychaudhuri, E M Farber
Archives of Dermatology|May 1, 1983
Long-term risks of psoralen and UV-A therapy for psoriasisE M Farber, E A Abel, A J Cox
Cutis|December 3, 1999
Search for the psoriasis susceptibility gene: the Newfoundland StudyL Nall, W Gulliver, P Charmley, et al.
Archives of Dermatology|April 1, 1975
Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivityV S Constantine, Z Y Fuks, E M Farber
Cancer|December 1, 1973
Prognostic signs and the management of the mycosis fungoidesZ Y Fuks, M A Bagshaw, E M Farber
International Journal of Dermatology|October 1, 1987
Psoriasis Day Care Center at Stanford. Part-time and full-time programsE A Abel, B M O'Connell, E M Farber
Pageof 15